FR3028955B1 - METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH - Google Patents

METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH

Info

Publication number
FR3028955B1
FR3028955B1 FR1461510A FR1461510A FR3028955B1 FR 3028955 B1 FR3028955 B1 FR 3028955B1 FR 1461510 A FR1461510 A FR 1461510A FR 1461510 A FR1461510 A FR 1461510A FR 3028955 B1 FR3028955 B1 FR 3028955B1
Authority
FR
France
Prior art keywords
predicting
sensitivity
patient
inhibitory treatment
mtor path
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1461510A
Other languages
French (fr)
Other versions
FR3028955A1 (en
Inventor
Chang Xian Zhang
Isabelle Treilleux
Thomas Bachelot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Leon Berard
Original Assignee
Centre Leon Berard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Leon Berard filed Critical Centre Leon Berard
Priority to FR1461510A priority Critical patent/FR3028955B1/en
Priority to PCT/FR2015/053217 priority patent/WO2016083741A1/en
Publication of FR3028955A1 publication Critical patent/FR3028955A1/en
Application granted granted Critical
Publication of FR3028955B1 publication Critical patent/FR3028955B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR1461510A 2014-11-26 2014-11-26 METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH Expired - Fee Related FR3028955B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1461510A FR3028955B1 (en) 2014-11-26 2014-11-26 METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH
PCT/FR2015/053217 WO2016083741A1 (en) 2014-11-26 2015-11-26 Method for predicting the sensitivity of a patient to treatment using mtor pathway inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1461510A FR3028955B1 (en) 2014-11-26 2014-11-26 METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH

Publications (2)

Publication Number Publication Date
FR3028955A1 FR3028955A1 (en) 2016-05-27
FR3028955B1 true FR3028955B1 (en) 2016-12-16

Family

ID=52824329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461510A Expired - Fee Related FR3028955B1 (en) 2014-11-26 2014-11-26 METHOD FOR PREDICTING THE SENSITIVITY OF A PATIENT TO INHIBITORY TREATMENT OF THE MTOR PATH

Country Status (2)

Country Link
FR (1) FR3028955B1 (en)
WO (1) WO2016083741A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1899463A4 (en) * 2005-05-09 2009-11-25 Ariad Pharma Inc Biomarkers for evaluating likelihood of tumor sensitivity to an mtor inhibitor
WO2007130590A2 (en) * 2006-05-04 2007-11-15 The Regents Of The University Of California Men1 is a marker and therapeutic target for breast and prostate cancer
WO2012094401A2 (en) * 2011-01-04 2012-07-12 The Johns Hopkins University Genes frequently altered in pancreatic neuroendocrine tumors

Also Published As

Publication number Publication date
WO2016083741A1 (en) 2016-06-02
FR3028955A1 (en) 2016-05-27

Similar Documents

Publication Publication Date Title
FR3021455B1 (en) PROCESS FOR FLOWING COPPER-FILLED EVIDENTS
FR3016710B1 (en) METHOD FOR PREDICTING AN OPERATIONAL MALFUNCTION OF AN AIRCRAFT OR AN AIRCRAFT FLEET
FR3028915B1 (en) FLUID CONNECTION SYSTEM AND METHOD OF MANUFACTURE
MA40354A (en) METHOD FOR PREDICTING THE RESULT OF TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED OF SUFFERING FROM CANCER
FR3026303B1 (en) DRYING METHOD OF MEDICAL DEVICE
FR3039368B1 (en) COSMETIC TREATMENT PROCESS
FR3034693B1 (en) METHOD OF MONITORING A MILLING PROCESS
FR2993973B1 (en) METHOD OF PROCESSING A FLIGHT PLAN
FR3030774B1 (en) METHOD FOR DETERMINING PARAMETERS OF A COMPRESSION FILTER AND MULTIVOYAL RADAR
FR3038312B1 (en) PROCESS FOR THE PREPARATION OF POLYOLS
FR3004540B1 (en) MICROFLUIDIC SYSTEM FOR EVALUATING THE EFFICACY OF AN ANTI-TRANSPIRANT PRODUCT AND ASSOCIATED METHOD
FR3026526B1 (en) METHOD AND SYSTEM FOR DETECTING EVENTS OF KNOWN NATURE
FR3017529B1 (en) METHOD AND SYSTEM FOR SURVEILLANCE OF THE AUTONOMOUS NERVOUS SYSTEM OF A SUBJECT
FR3012710B1 (en) PROCESS FOR PROCESSING SIGNALS DELIVERED BY PIXELS OF A DETECTOR
EP3371571C0 (en) Method of detecting neutrophil extracellular traps
FR3051555B1 (en) DETECTION OF RESIDUAL DISEASE OF MULTIPLE MYELOMA
FR3039649B1 (en) PROCESS FOR DETECTION OF OXIDIZING SPECIES
FR3027826B1 (en) SYSTEM AND METHOD FOR LOCAL SURFACE TREATMENT
FR3043823B1 (en) METHOD FOR DECAMOUFLING AN OBJECT
FR3021138B1 (en) EVENT CORRELATION ARCHITECTURE FOR SUPERCALCULATOR MONITORING
FR3021184B1 (en) PROCESS FOR TREATING SEEDS
FR3050271B1 (en) METHOD OF SEQUENCING OLIGOSACCHARIDES
FR3045171B1 (en) METHOD FOR MONITORING AN ELECTROMECHANICAL ACTUATION SYSTEM
FR3033063B1 (en) METHOD FOR DIGITAL CALCULATION OF DIFFRACTION OF A STRUCTURE
FR3019908B1 (en) METHOD OF PROCESSING SEISMIC IMAGES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Search report ready

Effective date: 20160527

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20180731